American Lung Association responds to higher rates of COVID-19 impacts among minorities

American Lung Association responds to higher rates of COVID-19 impacts among minorities

The world-first personalized nutrition wearable device “As our nation faces this pandemic, the American Lung Association calls on CDC to ensure that the impact of COVID-19 on minority populations is completely tracked, adequately addressed, and steps are taken to support the health of minority populations and communities. “While there is certainly more to learn about COVID-19 and its impact on minority populations, the factors that contribute toward this disparity are well known. COVID-19 underscores the health disparities that far too many Americans face. Access to quality and affordable healthcare, exposure to environmental hazards such as air pollution, and lack of access to resources all play a role in making far too many Americans more vulnerable to poor health, pre-existing conditions such as asthma and diabetes, and as a result – the more severe effects of COVID-19. “Quality and affordable healthcare that includes preventative care is essential to protecting the health of all Americans. By reducing preventable diseases and better controlling the symptoms of asthma and other lung diseases, we can save more lives not only during this pandemic but perhaps also the next. “Minority populations are disproportionately exposed to air pollution, which harms health and may make a person more vulnerable to COVID-19. A recent study from Harvard’s Chan School of Medicine indicates that long-term exposure to even small amounts of particle pollution can increase the death rate associated with COVID-19 by 15%. “The American Lung Association will continue to champion the health of all Americans and ensure everyone has access to quality and affordable healthcare, clean air and tobacco-free communities.” Source:



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More